Baxter International BAX Medical Products & Therapies — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's medical products & therapies — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's medical products & therapies — goodwill?
- Baxter International (BAX) reported medical products & therapies — goodwill of $1.25B in Q1 2026.
- How has Baxter International's medical products & therapies — goodwill changed year-over-year?
- Baxter International's medical products & therapies — goodwill increased by 2.0% year-over-year, from $1.22B to $1.25B.
- What does medical products & therapies — goodwill mean?
- The value of intangible assets like brand and customer base attributed to this business segment from past acquisitions.
- How do you interpret medical products & therapies — goodwill?
- An increase suggests recent acquisitions, while a decrease may indicate asset write-downs or divestitures.
- How does medical products & therapies — goodwill compare across companies?
- Standard across medical device peers reporting segment-level intangible assets.